HPTN 077: No Significant Weight Gain at Week 41 With Long-Acting CAB vs PBO in HIV-Uninfected Persons at Low Risk for Infection

March 4-7, 2019; Seattle, Washington
Post hoc analysis finds no evidence of association between cabotegravir use and weight gain.
Format: Microsoft PowerPoint (.ppt)
File Size: 174 KB
Released: March 11, 2019


Directly provided by the Annenberg Center for Health Sciences at Eisenhower

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)

This program is supported by independent educational grants from
Gilead Sciences
Janssen Therapeutics
Merck & Co., Inc.
ViiV Healthcare

Related Content

Expert commentary from Anthony Mills, MD, on his optimistic outlook for patient uptake of long-acting injectable ART.

Anthony M. Mills, MD Released: December 11, 2019

Clinical Care Options’ expert audio on managing heavily treatment-experienced patients with HIV by Joseph J. Eron, Jr., MD, and Paul E. Sax, MD

Joseph J. Eron, Jr., MD Paul E. Sax, MD Released: October 15, 2019

Expert commentary from Babafemi Taiwo, MBBS, on less frequent dosing regimens offered by investigational HIV drugs in the prevention and treatment pipeline

Babafemi Taiwo, MBBS Released: October 10, 2019

Expert commentary: Andrea Mantsios on candidates for long-acting ART. Patient research from ATLAS, FLAIR, LATTE-2: injectable cabotegravir + rilpivirine

Andrea Mantsios, PhD Released: September 27, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?